Relating to: regulating hemp-derived cannabinoid products.

AB 747 regulates hemp-derived cannabinoid products like delta-8, delta-9, and delta-10 THC gummies or edibles. It requires third-party lab testing for potency, safety (e.g., pesticides, heavy metals), and THC content (max 0.3% or federal max 1%), mandates clear labeling with batch numbers and manufacturer details, and bans sales to people under 21. The bill excludes prescription drugs and certain CBD products governed by separate laws. Businesses must provide test results via QR codes or labels at point of sale.